BFC Planning’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
BFC Planning's CPRX Position: Q3 2026 in Review
BFC Planning sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 173 shares — an estimated $5.44K sold.
BFC Planning first reported a position in CPRX in Q4 2024 and held it in 6 quarters. The position peaked at $317K in Q1 2025. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- BFC Planning reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- BFC Planning sold 173 Catalyst Pharmaceutical shares in Q3 2026, an estimated $5.44K.
- BFC Planning first reported a position in Catalyst Pharmaceutical in Q4 2024 and held it in 6 quarters.
- BFC Planning's Catalyst Pharmaceutical position peaked at $317K in Q1 2025.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.